LRRC15 is a new cancer-associated fibroblast and mesenchymal marker that is overexpressed in OS tissue samples and is being investigated as a potential therapeutic target for ADC-based sarcoma treatment (38, 39). The gene discussed is LRRC15; the disease is cancer.